Walleye Capital
SOPH icon

Walleye Capital’s SOPHiA GENETICS SOPH Stock Holding History

Walleye Capital’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.6K Buy
+11,543
New +$58.6K ﹤0.01% 4076

Other funds holding SOPH

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
FDS
First Dallas Securities Dallas, Texas $303M AUM 47.81% 1-Year Est. Return

Walleye Capital's SOPH Position: Q2 2026 in Review

Walleye Capital opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 11,543 shares worth $66.6K. The stake represents ﹤0.01% of the portfolio and ranks #4076 among its holdings.

16 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Walleye Capital held 11,543 shares of SOPHiA GENETICS worth $66.6K as of Q2 2026.
  • SOPHiA GENETICS was a new Walleye Capital position in Q2 2026.
  • SOPHiA GENETICS made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4076 holding.
  • 16 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.